terminal pro-B-type natriuretic peptide testing in patients presenting to the Emergency Department With acute dyspnoea: evaluation of effects on treatment, hospitalisation rate and costs
Not Applicable
Completed
- Conditions
- Cost-effectiveness, dyspnoea, amino-terminal pro B-type natriuretic peptideRespiratoryDyspnoea
- Registration Number
- ISRCTN28653133
- Lead Sponsor
- Erasmus Medical Centre (The Netherlands)
- Brief Summary
2008 Results article in https://doi.org/10.1016/j.ahj.2008.02.021 (added 25/10/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 477
Inclusion Criteria
1. Age 18 years or older
2. Acute dyspnoea as the most prominent complaint
Exclusion Criteria
1. Acute dyspnoea due to a trauma
2. Acute dyspnoea due to cardiogenic shock
3. Renal failure requiring dialysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method